DE60134956D1 - Gene differentiell experimiert in brudtkrebs - Google Patents

Gene differentiell experimiert in brudtkrebs

Info

Publication number
DE60134956D1
DE60134956D1 DE60134956T DE60134956T DE60134956D1 DE 60134956 D1 DE60134956 D1 DE 60134956D1 DE 60134956 T DE60134956 T DE 60134956T DE 60134956 T DE60134956 T DE 60134956T DE 60134956 D1 DE60134956 D1 DE 60134956D1
Authority
DE
Germany
Prior art keywords
brudtkrebs
experimented
gene differentially
seq
cancer cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60134956T
Other languages
German (de)
English (en)
Inventor
Joerg Kaufmann
Greg Harrowe
Christoph Reinhard
Sanmao Kang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Novartis Vaccines and Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines and Diagnostics Inc filed Critical Novartis Vaccines and Diagnostics Inc
Application granted granted Critical
Publication of DE60134956D1 publication Critical patent/DE60134956D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60134956T 2000-01-10 2001-01-09 Gene differentiell experimiert in brudtkrebs Expired - Lifetime DE60134956D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17546200P 2000-01-10 2000-01-10
PCT/US2001/000899 WO2001051515A2 (en) 2000-01-10 2001-01-09 Genes differentially expressed in breast cancer

Publications (1)

Publication Number Publication Date
DE60134956D1 true DE60134956D1 (de) 2008-09-04

Family

ID=22640304

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60134956T Expired - Lifetime DE60134956D1 (de) 2000-01-10 2001-01-09 Gene differentiell experimiert in brudtkrebs

Country Status (9)

Country Link
US (1) US7605246B2 (enExample)
EP (2) EP1985701B1 (enExample)
JP (2) JP5250168B2 (enExample)
AT (1) ATE402258T1 (enExample)
AU (1) AU2001229367A1 (enExample)
DE (1) DE60134956D1 (enExample)
ES (2) ES2311016T3 (enExample)
PT (1) PT1248841E (enExample)
WO (1) WO2001051515A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081517B2 (en) * 2000-01-10 2006-07-25 Chiron Corporation Genes differentially expressed in breast cancer
DE102011110592A1 (de) 2011-08-18 2013-02-21 Rena Gmbh Verfahren zum Konditionieren von flachen Gegenständen
CN112837822B (zh) * 2020-09-24 2023-05-02 广州市疾病预防控制中心(广州市卫生检验中心、广州市食品安全风险监测与评估中心、广州医科大学公共卫生研究院) 预测covid-19患者发生轻至重度进展的标志物及试剂盒和建立方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
IE58011B1 (en) 1983-05-27 1993-06-16 Texas A & M Univ Sys Method for producing a recombinant baculovirus expression vector
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
ZA848495B (en) 1984-01-31 1985-09-25 Idaho Res Found Production of polypeptides in insect cells
US4837148A (en) 1984-10-30 1989-06-06 Phillips Petroleum Company Autonomous replication sequences for yeast strains of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
IL77186A0 (en) 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
US4929555A (en) 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
DE68925971T2 (de) 1988-09-23 1996-09-05 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
FR2649120B1 (fr) 1989-06-30 1994-01-28 Cayla Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede
WO1991016116A1 (en) 1990-04-23 1991-10-31 Cellpro Incorporated Immunoselection device and method
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
IT1254309B (it) 1992-02-17 1995-09-14 Uni Degli Studi G D Annunzio C Sequenze genetiche per l'antigene 90k associato a tumori.
EP0616802B1 (en) 1992-08-13 1998-06-17 Teikoku Seiyaku Co., Ltd. Oral preparation for release in lower digestive tracts
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
JP2003514543A (ja) * 1999-11-19 2003-04-22 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ２３個のヒト分泌タンパク質

Also Published As

Publication number Publication date
JP5250168B2 (ja) 2013-07-31
US7605246B2 (en) 2009-10-20
JP2003519480A (ja) 2003-06-24
ATE402258T1 (de) 2008-08-15
JP2012143242A (ja) 2012-08-02
ES2311016T3 (es) 2009-02-01
EP1985701A2 (en) 2008-10-29
EP1985701A3 (en) 2009-01-07
ES2386317T3 (es) 2012-08-17
WO2001051515A2 (en) 2001-07-19
US20020004239A1 (en) 2002-01-10
EP1248841A2 (en) 2002-10-16
EP1248841B1 (en) 2008-07-23
EP1985701B1 (en) 2012-05-30
HK1118861A1 (en) 2009-02-20
WO2001051515A3 (en) 2002-01-24
PT1248841E (pt) 2008-09-15
AU2001229367A1 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
ATE386804T1 (de) Gene mit veränderter expression in metastatischen brust- oder dickdarm- krebszellen
AU1726199A (en) Metastatic cancer regulated gene
ATE190313T1 (de) Dns-sequenz und kodiertes brustdrüsenspezifisisches brustkrebsprotein
TR200003685T1 (tr) Bir salgılanmış meme kanseri proteini olan mamaglobin
ATE478952T1 (de) 36p6d5: ausgeschiedenes tumorprotein
ATE422536T1 (de) Zusammensetzungen und methoden zur diagnose von tumoren
WO1999014327A3 (en) Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer
WO2002029086A3 (en) Nucleic acid sequences differentially expressed in cancer tissue
RU2001104349A (ru) Композиции и способы для терапии и диагностики рака предстательной железы
KR100517848B1 (en) Compositions and Methods for The Treatment of Tumor
TR200101702T2 (tr) Mammaglobin, göğse özgü salgılanan bir göğüs kanseri proteini.
DE60134956D1 (de) Gene differentiell experimiert in brudtkrebs
DE69837935D1 (de) Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden
WO2002044419A3 (en) Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
EP1693457A3 (en) Metastatic breast and colon cancer regulated genes
WO1999043812A3 (en) Dlc-1 gene, a putative tumors suppressor gene
WO2002042460A3 (en) Compositions and methods relating to colon specific genes and proteins

Legal Events

Date Code Title Description
8364 No opposition during term of opposition